MD Compliance supports medical device companies in implementing risk management processes that are practical, defensible, and fully aligned with regulatory expectations. We help you move beyond checkbox compliance with ISO 14971, ensuring risk management actively supports safe device design, robust technical documentation, and clear, credible claims while remaining proportionate to your organisation and product risk profile.
ISO 14971 is the internationally recognised standard governing risk management for medical devices and forms the foundation of regulatory expectations under the EU MDR, UK MDR, FDA requirements, and other global frameworks. The standard requires manufacturers to systematically identify hazards, estimate and evaluate associated risks, implement appropriate risk control measures, and assess residual risk throughout the device lifecycle.
We support clients in the development, implementation, and maintenance of ISO 14971 compliant risk management processes and documentation tailored to their specific devices and technologies. This includes establishing risk management plans, identifying appropriate hazards, defining risk acceptability criteria, and ensuring consistent application of risk analysis methods such as FMEA, fault tree analysis, and use-related risk analysis. Our approach prioritises clarity, consistency, and traceability, ensuring risk management outputs are robust, usable, and suitable for regulatory assessment.
At MD Compliance, we specialise in the practical application of risk management, working directly with engineering, clinical, and quality teams to ensure actual risks are identified and controlled where they arise not retrospectively documented. Our consultants have hands-on experience managing complex risk management activities across a wide range of medical devices, from early-stage development through to post-market support.
We facilitate hazard identification workshops, support the development and maintenance of risk analyses with sensible risk prioritization, and assist with defining and implementing appropriate and verifiable risk control measures. We also help teams evaluate the effectiveness of those controls, justify residual risks, and document benefit–risk conclusions in a clear and defensible manner. For startups and SMEs, this collaborative approach builds internal capability while keeping development timelines and regulatory expectations aligned.
Use-error and usability-related risks are a major focus for regulators and assessment bodies, particularly under the EU MDR, FDA requirements, and IEC 62366-1. Many serious incidents and regulatory findings arise not from device failure, but from predictable user interaction issues including unclear interfaces, ambiguous labelling, or use environments that were not adequately considered during design and development.
MD Compliance supports clients in identifying, analyzing, and controlling use-related risks as an integral part of the overall risk management process. We help define intended users, use environments, and reasonably foreseeable misuse, and ensure these factors are systematically assessed alongside technical hazards. Our team supports the development of use-related risk analyses, including task analysis and identification of critical user interactions that could lead to harm.
We also help integrate usability engineering outputs into the risk management file, technical documentation, and IFU. This includes aligning usability validation activities with identified risks, ensuring risk controls are implemented through design or user information, and confirming that residual use-related risks are clearly and consistently communicated. By embedding usability risk management early, we help reduce regulatory risk while improving overall device safety and user experience.
Risk management underpins almost every element of medical device technical documentation. Regulators expect clear traceability between identified risks, design controls, verification and validation activities, and post-market surveillance outputs. Inconsistencies between the risk management file and the technical documentation are a common source of regulatory findings.
We support clients in aligning risk management files with technical documentation, ensuring coherence across design inputs, risk controls, test reports, clinical evidence, and post-market plans. Our reviews focus on traceability and consistency, helping you present a clear and credible risk narrative to Notified Bodies, Approved Bodies, and other regulatory authorities.
Device claims and user-facing information represent a critical interface between risk management and regulatory compliance. Regulators expect all performance and safety claims to be supported by evidence and for residual risks to be appropriately communicated through labelling and the Instructions for Use (IFU).
MD Compliance supports clients in ensuring that risk management outputs are fully aligned with device claims and IFU content. We review claims to confirm they are supported by risk controls and verifiable evidence, and we assess IFUs to ensure warnings, precautions, contraindications, and residual risks are clearly and consistently presented. This integrated approach reduces regulatory findings, supports safer device use, and strengthens overall compliance.
